Hjem
Ottar Nygårds bilde

Ottar Nygård

Professor
  • E-postOttar.Nygard@uib.no
  • Telefon+47 55 97 30 64
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • 2019. Using metabolic profiling and gene expression analyses to explore molecular effects of replacing saturated fat with polyunsaturated fat-a randomized controlled dietary intervention study. American Journal of Clinical Nutrition. 1239-1250.
  • 2019. Short-term activation of peroxisome proliferator-activated receptors α and γ induces tissue-specific effects on lipid metabolism and fatty acid composition in male Wistar rats. PPAR Research. 1-12.
  • 2019. Plasma amino acids and incident type 2 diabetes in patients with coronary artery disease. Diabetes Care. 1225-1233.
  • 2019. Hypertensive pregnancy disorders increase the risk of maternal cardiovascular disease after adjustment for cardiovascular risk factors. International Journal of Cardiology. 81-87.
  • 2019. Elevated plasma cystathionine is associated with increased risk of mortality among patients with suspected or established coronary heart disease. American Journal of Clinical Nutrition. 1546-1554.
  • 2019. Creatinine, total cysteine and uric acid are associated with serum retinol in patients with cardiovascular disease. European Journal of Nutrition.
  • 2019. Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain-the WESTCOR study: study design. Scandinavian Cardiovascular Journal. 280-285.
  • 2019. A mitochondria-targeted fatty acid analogue influences hepatic glucose metabolism and reduces the plasma insulin/glucose ratio in male Wistar rats. PLOS ONE. 1-17.
  • 2018. Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans. The FASEB Journal. 6019-6024.
  • 2017. Visceral adiposity and metabolic syndrome after very high-fat and low-fat isocaloric diets: A randomized controlled trial. American Journal of Clinical Nutrition. 85-99.
  • 2017. Time trends and educational inequalities in out-of-hospital coronary deaths in Norway 1995-2009: A Cardiovascular Disease in Norway (CVDNOR) project. Journal of the American Heart Association. 8 sider.
  • 2017. Dietary choline intake is directly associated with bone mineral density in the Hordaland Health Study. Journal of Nutrition. 572-578.
  • 2017. Cardiovascular disease risk associated with serum apolipoprotein B is modified by serum vitamin A. Atherosclerosis. 325-330.
  • 2017. Associations between intake of fish and n-3 long-chain polyunsaturated fatty acids and plasma metabolites related to the kynurenine pathway in patients with coronary artery disease. European Journal of Nutrition. 261-272.
  • 2016. Vitamin B-6 catabolism and long-term mortality risk in patients with coronary artery disease. American Journal of Clinical Nutrition. 1417-1425.
  • 2016. The universal 2012 definition of myocardial infarction compared to the 2007 definition. Scandinavian Cardiovascular Journal. 201-205.
  • 2016. The antihypertensive MTHFR gene polymorphism rs17367504-G is a possible novel protective locus for preeclampsia. Journal of Hypertension. 132-139.
  • 2016. Tetradecylthiopropionic acid induces hepatic mitochondrial dysfunction and steatosis, accompanied by increased plasma homocysteine in mice. Lipids in Health and Disease. 16 sider.
  • 2016. Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study. Lipids in Health and Disease.
  • 2016. Prospective associations of systemic and urinary choline metabolites with incident type 2 diabetes. Clinical Chemistry. 755-765.
  • 2016. Plasma glycine and risk of acute myocardial infarction in patients with suspected stable angina pectoris. Journal of the American Heart Association. 9 sider.
  • 2016. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. European Heart Journal. 1967-1976.
  • 2016. Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality: The Hordaland Health Study. American Journal of Epidemiology. 249-258.
  • 2016. Peroxisome Proliferator-Activated Receptor Activation is Associated with Altered Plasma One-Carbon Metabolites and B-Vitamin Status in Rats. Nutrients.
  • 2016. Heart Failure Complicating Acute Myocardial Infarction; Burden and Timing of Occurrence: A Nation-wide Analysis Including 86 771 Patients From the Cardiovascular Disease in Norway (CVDNOR) Project. Journal of the American Heart Association. 8 sider.
  • 2016. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease . New England Journal of Medicine. 1242-1252.
  • 2016. Cosinor modelling of seasonal variation in 25-hydroxyvitamin D concentrations in cardiovascular patients in Norway. European Journal of Clinical Nutrition. 517-522.
  • 2016. Coronary angiography and myocardial revascularization following the first acute myocardial infarction in Norway during 2001-2009: Analyzing time trends and educational inequalities using data from the CVDNOR project. International Journal of Cardiology. 122-128.
  • 2016. B vitamin treatments modify the risk of myocardial infarction associated with a MTHFD1 polymorphism in patients with stable angina pectoris. NMCD. Nutrition Metabolism and Cardiovascular Diseases. 495-501.
  • 2016. Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris. PLOS ONE.
  • 2015. Use of loop diuretics is associated with increased mortality in patients with suspected coronary artery disease, but without systolic heart failure or renal impairment: an observational study using propensity score matching. PLOS ONE. 13 sider.
  • 2015. Refined phenotyping identifies links between preeclampsia and related diseases in a Norwegian preeclampsia family cohort. Journal of Hypertension. 2294-2302.
  • 2015. Plasma dimethylglycine, nicotine exposure and risk of low bone mineral density and hip fracture: the Hordaland Health Study. Osteoporosis International. 1573-1583.
  • 2015. Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris. European Journal of Preventive Cardiology (EJPC). 606-614.
  • 2015. Non-fasting triglycerides predict incident acute myocardial infarction among those with favourable HDL-cholesterol: Cohort Norway. European Journal of Preventive Cardiology (EJPC). 872-881.
  • 2015. Kynurenines as predictors of acute coronary events in the Hordaland Health Study. International Journal of Cardiology. 18-24.
  • 2015. Hypertriglyceridemic-Waist Phenotype is a Useful Global Assessment Tool for Predicting Acute Myocardial Infarction. Journal of Cardiovascular Diseases & Diagnosis. 1-6.
  • 2015. Effect of the Lookback period's length used to identify incident acute myocardial infarction on the observed trends on incidence rates and survival: cardiovascular disease in Norway project. Circulation. Cardiovascular Quality and Outcomes. 376-382.
  • 2015. Clinical significance of late enhancement and regional wall remodeling assessed by 3T magnetic resonance imaging. Clinical Medicine Insights: Cardiology. 17-24.
  • 2015. Circulating B-vitamins and smoking habits are associated with serum polyunsaturated fatty acids in patients with suspected coronary heart disease: A cross-sectional study. PLOS ONE. 14 sider.
  • 2015. A protein extract from chicken reduces plasma homocysteine in rats. Nutrients. 4498-4511.
  • 2015. A Phospholipid-Protein Complex from Antarctic Krill Reduced Plasma Homocysteine Levels and Increased Plasma Trimethylamine-N-Oxide (TMAO) and Carnitine Levels in Male Wistar Rats. Mar. Drugs. Marine Drugs. 5706-5721.
  • 2014. Trends in acute myocardial infarction event rates and risk of recurrences after an incident event in Norway 1994 to 2009 (from a cardiovascular disease in Norway project). American Journal of Cardiology. 1777-1781.
  • 2014. Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer – a large nested case-control study within the JANUS cohort in Norway. International Journal of Cancer. 197-206.
  • 2014. Plasma choline, nicotine exposure, and risk of low bone mineral density and hip fracture: the Hordaland Health Study. Journal of Bone and Mineral Research. 242-250.
  • 2014. Implications of changing definitions of myocardial infarction on number of events and all-cause mortality: the WHO 1979, ESC/ACC 2000, AHA 2003, and Universal 2007 definitions revisited. European Journal of Preventive Cardiology (EJPC). 1349-1357.
  • 2014. Hypolipidemic effect of dietary water-soluble protein extract from chicken: impact on genes regulating hepatic lipid and bile acid metabolism. European Journal of Nutrition. 193-204.
  • 2014. Favorable trends in incidence of AMI in Norway during 2001-2009 do not include younger adults: a CVDNOR project. European Journal of Preventive Cardiology (EJPC). 1358-1364.
  • 2013. Urinary excretion of kynurenine and tryptophan, cardiovascular events, and mortality after elective coronary angiography. European Heart Journal. 2689-2696.
  • 2013. Type 2 diabetes genes : present status and data from Norwegian studies. Norsk Epidemiologi. 9-22.
  • 2013. The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine. PLOS ONE. 9 sider.
  • 2013. Substrate product ratios of enzymes in the kynurenine pathway measured in plasma as indicators of functional vitamin B-6 status. American Journal of Clinical Nutrition. 934-940.
  • 2013. Serum folate and vitamin B12 concentrations in relation to prostate cancer risk-a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort. International Journal of Epidemiology. 201-210.
  • 2013. Preeclampsia in healthy women and endothelial dysfunction 10 years later. American Journal of Obstetrics and Gynecology. 569.e1-569.e10.
  • 2013. Plasma sulfur amino acids and stearoyl-CoA desaturase activity in two caucasian populations. Prostaglandins Leukot Essent Fatty Acids 2. Prostaglandins, Leukotrienes and Essential Fatty Acids. 297-303.
  • 2013. Plasma stearoyl-CoA desaturase indices: Association with lifestyle, diet and body composition. Obesity. E294-E302.
  • 2013. Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris. Arteriosclerosis, Thrombosis and Vascular Biology. 2041-2048.
  • 2013. Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. International Journal of Cardiology. 1435-1440.
  • 2013. Fish Oil and the Pan-PPAR Agonist Tetradecylthioacetic Acid Affect the Amino Acid and Carnitine Metabolism in Rats. PLOS ONE. 9 sider.
  • 2013. Evaluation of the body adiposity index in a caucasian population: the Hordaland Health Study. American Journal of Epidemiology. 586-592.
  • 2013. Effect of folic acid supplementation on levels of circulating monocyte chemoattractant protein-1 and the presence of intravascular ultrasound derived virtual histology thin-cap fibroatheromas in patients with stable angina pectoris. PLOS ONE. 11 sider.
  • 2013. Dietary intake of n-3 long-chain polyunsaturated fatty acids and risk of myocardial infarction in coronary artery disease patients with or without diabetes mellitus: a prospective cohort study. BMC Medicine.
  • 2013. Cardiovascular disease and diabetes mellitus in Norway during 1994 -2009: CVDNOR - nationwide research project. Norsk Epidemiologi. 101-107.
  • 2013. Associations between plasma polyunsaturated fatty acids, plasma stearoyl-CoA desaturase indices and body fat. Obesity. E512-E519.
  • 2013. Assessment of urinary betaine as a marker of diabetes mellitus in cardiovascular patients. PLOS ONE.
  • 2013. An immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoE(-/-) mice. PLOS ONE. 14 sider.
  • 2013. A randomised study on the effects of fish protein supplement on glucose tolerance, lipids and body composition in overweight adults. British Journal of Nutrition. 648-657.
  • 2013. A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study. Clinical and Experimental Immunology. 121-130.
  • 2012. Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidism. Journal of Internal Medicine. 583-591.
  • 2012. Relative importance of risk factors for coronary heart disease - The Hordaland Homocysteine Study. Scandinavian Cardiovascular Journal. 316-323.
  • 2012. Omega-3 status and the relationship between plasma asymmetric dimethylarginine and risk of myocardial infarction in patients with suspected coronary artery disease. Cardiology Research and Practice. 11 sider.
  • 2012. Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia. Obstetrics and Gynecology. 1243-1250.
  • 2012. Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat. Lipids in Health and Disease. 11 sider.
  • 2012. Krill powder increases liver lipid catabolism and reduces glucose mobilization in tumor necrosis factor-alpha transgenic mice fed a high-fat diet. Metabolism: Clinical and Experimental. 1461-1472.
  • 2012. Free carnitine and acylcarnitines in obese patients with polycystic ovary syndrome and effects of pioglitazone treatment. Fertility and Sterility. 1620-1626,e1.
  • 2012. Association of plasma B-6 vitamers with systemic markers of inflammation before and after pyridoxine treatment in patients with stable angina pectoris. American Journal of Clinical Nutrition. 1072-1078.
  • 2011. Systemic Markers of Interferon-gamma-Mediated Immune Activation and Long-Term Prognosis in Patients With Stable Coronary Artery Disease. Arteriosclerosis, Thrombosis and Vascular Biology. 698-704.
  • 2011. Poor folate status predicts persistent diarrhea in 6- to 30-month-old north Indian children. Journal of Nutrition. 2226-2232.
  • 2011. Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation. Journal of Nutrition. 611-617.
  • 2011. Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12. Coronary Artery Disease. 270-278.
  • 2011. Cobalamin Status Modifies the Effect of Zinc Supplementation on the Incidence of Prolonged Diarrhea in 6-to 30-Month-Old North Indian Children. Journal of Nutrition. 1108-1113.
  • 2011. A proposed method to investigate reliability throughout a questionnaire. BMC Medical Research Methodology. 7 sider.
  • 2010. Trends in incidence and mortality for triplets in Norway 1967-2006: the influence of assisted reproductive technologies. BJOG: An International Journal of Obstetrics and Gynaecology. 667-675.
  • 2010. Systemic Markers of Interferon-–Mediated Immune Activation and Long-Term Prognosis in Patients With Stable Coronary Artery Disease. Arteriosclerosis, Thrombosis and Vascular Biology.
  • 2010. Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris. Atherosclerosis. 644-649.
  • 2010. Serum B vitamin levels and risk of lung cancer. Journal of the American Medical Association (JAMA). 2377-2385.
  • 2010. Long- and short-term effects of tobacco smoking on circulating concentrations of B vitamins. Clinical Chemistry. 755-763.
  • 2010. Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a western Norway B vitamin intervention trial (WENBIT) substudy. American Journal of Cardiology. 1577-1584.
  • 2010. Dietary intake of n-3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease. American Journal of Clinical Nutrition. 244-251.
  • 2010. Competing risk analysis of events 10 years after revascularization. Scandinavian Cardiovascular Journal. 279-288.
  • 2010. Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. Journal of Internal Medicine. 367-382.
  • 2009. Short-term and long-term case fatality in 11 878 patients hospitalized with a first acute myocardial infarction, 1979-2001: the Western Norway cardiovascular registry. European Journal of Cardiovascular Prevention & Rehabilitation. 621-627.
  • 2009. Quantitative contrast stress echocardiography in assessment of restenosis after percutaneous coronary intervention in stable coronary artery disease. European Heart Journal-Cardiovascular Imaging. 858-864.
  • 2009. Myocardial Contrast Echocardiography in Assessment of Stable Coronary Artery Disease at Intermediate Dobutamine-Induced Stress Level. Echocardiography. 52-60.
  • 2009. Cysteine, homocysteine and bone mineral density: A role for body composition? Bone. 954-958.
  • 2009. Cancer incidence and mortality after treatment with folic acid and vitamin B12. Journal of the American Medical Association (JAMA). 2119-2126.
  • 2008. Sykehusinnleggelser for hjerte- og karsykdom i Helse Vest i perioden 1992-2001. Tidsskrift for Den norske legeforening. 17-23.
  • 2008. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography - A Randomized controlled trial. Journal of the American Medical Association (JAMA). 795-804.
  • 2008. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? American Journal of Clinical Nutrition. 738-746.
  • 2008. Factor structure of the revised Jalowiec Coping Scale in patients admitted for elective coronary angiography*. Scandinavian Journal of Caring Sciences. 596-607.
  • 2008. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. Journal of Nutrition. 914-920.
  • 2008. Comparison of the Short Form 36 and the Hospital Anxiety and Depression Scale measuring emotional distress in patients admitted for elective coronary angiography. Heart & Lung. 286-295.
  • 2008. Comparison of the Short Form 36 and the Hospital Anxiety and Depression Scale measuring emotional distress in patients admitted for elective coronary angiography. Heart & Lung. 286-295.
  • 2008. Associations between disease severity, coping and dimensions of health-related quality of life in patients admitted for elective coronary angiography - a cross sectional study. Health and Quality of Life Outcomes. 12 sider.
  • 2008. Associations between disease severity, coping and dimensions of health-related quality of life in patients admitted for elective coronary angiography - a cross sectional study. Health and Quality of Life Outcomes. 12.
  • 2007. Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 514-521.
  • 2007. Plasma creatinine as a determinant of plasma total homocysteine concentrations in the Hordaland Homocysteine Study: Use of statistical modeling to determine reference limits. Clinical Biochemistry. 1209-1218.
  • 2007. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. Journal of Internal Medicine. 244-253.
  • 2007. Cognitive performance among the elderly and dietary fish intake: the Hordaland Health Study. American Journal of Clinical Nutrition. 1470-1478.
  • 2007. Changes in Atherosclerotic Plaque Volume Measured with Intracoronary Ultrasound during B-vitamin Intervention (a WENBIT substudy). Clinical Chemistry and Laboratory Medicine. A50-P44.
  • 2006. The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease. Journal of Nutrition. 1731-1740.
  • 2006. Relationship between provider-based measures of physical function and self-reported health-related quality of life in patients admitted for elective coronary angiography. Heart & Lung. 11 sider.
  • 2006. Relationship between probider-based measures of physical function and self-reported health-realted quality of life in pasients admitted for elective coronary angiafraphy. Heart & Lung. 90-100.
  • 2006. Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. American Heart Journal. 282-287.
  • 2006. Effect of vitamin B-12 treatment on haptocorrin. Clinical Chemistry. 1104-1111.
  • 2005. Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations. European Journal of Clinical Nutrition. 480-488.
  • 2005. Fc gamma receptor IIIA polymorphism as a risk-factor for coronary artery disease. Atherosclerosis. 277-282.
  • 2004. Changes in lifestyle and plasma total homocysteine. The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 812-819.
  • 2004. Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention. American Journal of Clinical Nutrition. 641-648.
  • 2004. Blood pressure measurements by the Keito machine. Evaluation versus office blood pressure by physicians. Blood Pressure Monitoring. 167-172.
  • 2004. Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation. Arteriosclerosis, Thrombosis and Vascular Biology. 301-307.
  • 2003. Plasma Vitamin B6 Vitamers before and after Oral Vitamin B6 Treatment: A Randomized Placebo-controlled Study. Clinical Chemistry. 155-161.
  • 2003. Homocysteinstudien i Hordaland. Norsk Epidemiologi. 103-106.
  • 2002. Plasma total homocysteine and hospitalizations for cardiovascular disease: The Hordaland Homocysteine Study. Archives of Internal Medicine. 1374-1381.
  • 2002. Holo-Transcobalamin Is an Early Marker of Changes in Cobalamin Homeostasis. A Randomized Placebo-controlled Study. Clinical Chemistry. 1768-1771.
  • 2001. Plasma total homocysteine is influenced by prandial status in humans: The Hordaland Homocysteine Study. Journal of Nutrition. 1214-1216.
  • 2001. Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment. Clinical Chemistry. 1738-1741.
  • 2001. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 130-136.
  • 1999. Apolipoprotein A1 and risk for coronary artery disease. Scandinavian Cardiovascular Journal. 19.
  • 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • 1998. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study [see comments]. American Journal of Clinical Nutrition. 263-270.
  • 1998. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 263-270.
  • 1998. Homocysteine and cardiovascular disease. Annual Review of Medicine. 31-62.
  • 1998. Homocysteine and cardiovascular disease. Annual Review of Medicine. 31-62.
  • 1998. Homocystein og koronarsykdom. Lipid-forum. 17-22.
  • 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • 1997. Homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. Norsk Epidemiologi. 221-224.
  • 1997. Homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. Norsk Epidemiologi. 221-224.
  • 1997. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • 1997. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • 1997. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • 1996. The Hordaland homocysteine study: The opposite tails odds ratios (OTOR) reveal differential effects og gender and intake of vitamin supplements at high and low plasma homocysteine concentrations. Journal of Nutrition. 1244S-1248S.
  • 1996. The Hordaland homocysteine study: The opposite tails odds ratios (OTOR) reveal differential effects og gender and intake of vitamin supplements at high and low plasma homocysteine concentrations. Journal of Nutrition. 1244S-1248S.
  • 1996. Determinants and vitamin responsiveness of the intermediate homohypercysteinemia (> 40 _mmol/L). The Hordaland homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • 1996. Determinants and vitamin responsiveness of the intermediate homohypercysteinemia (> 40 _mmol/L). The Hordaland homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • 1996. Determinants and Vitamin Responsiveness of Intermediate Hyperhomocysteinemia (@z _mmol/liter). The Hordaland Homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • 1995. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. Journal of the American Medical Association (JAMA). 1526-1533.
  • 1995. Kolesterolbestemmelse ved sesjon. En måte å identifisere personer med høy risiko for å utvikle hjerte- og karsykdom. Tidsskrift for Den norske legeforening. 3249-3253.
Vitenskapelig foredrag
  • 2018. Using metabolic profiling to explore molecular effects of replacing saturated fat with polyunsaturated fat- a randomized controlled dietary intervention study.
  • 2017. Association between dietary fat intake and coronary heart disease in middle-age adults. The Hordaland Health Study (HUSK) .
  • 2015. Fibrinogen And Neopterin Predict Future Myocardial Infarction Events In Patients With Stable Coronary Heart Disease. Circulation. 2015;132:A19224.
  • 2014. VITAMIN D STATUS AND MORTALITY IN PATIENTS WITH STABLE ANGINA.
  • 2013. Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi.
  • 2010. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
  • 2007. WENBIT -Western Norway B-vitamin Intervention Trial: P96, Clinical Chemistry & Laboratory Medicine. 45(5):A18, May 2007.
  • 2007. WENBIT - Western Norway B-vitamin intervention trial.
  • 2007. Total homocysteine, systemic markers of inflammation and long-term mortality in patients with stable angina.
  • 2007. Components of the metabolic syndrome and other cardiovascular risk factors as predictors of plasma choline and betaine.
  • 2007. Asymmetric and symmetric dimethylarginine are weaker predictors than homocysteine of long-term mortality in patients with stable angina.
  • 2002. Total homocysteine levels predicts major coronary events and mortaliy in simvastatin treated patients of 4S.
  • 2001. Total homocysteine predicts mortality and major coronary events also in simvastatin treated patients of 4S.
  • 2001. Total homocysteine predicts major coronary events and mortality in simvastatin treated patients of 4S.
  • 2001. Total Homocysteine Levels Predicts Major Coronary Events and Mortality in Simvastatin Treated Patients of 4S.
  • 2001. Homocysteine predicts mortality and coronary events in 4S patients.
  • 1999. Plasma levels of homocysteine are changed during treatment of hyper- and hypothyroidism.
  • 1999. Apolipoprotein A1 and risk for coronary artery disease.
  • 1998. Plasma total homocysteine: a risk factor for mortality in aortic stenosis patients.
  • 1997. Total mortality and serum uric acid in patients with confirmed coronary artery disease.
  • 1997. Plasma homocysteine predicts mortality in coronary artery diseased patients.
  • 1997. Plasma homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. [Poster].
  • 1995. Plasma homocysteine and relation to coffee and tea comsimption.
  • 1995. Plasma homocystein og forbruk av kaffe og te.
Sammendrag/abstract
  • 2015. A genetic connection between preeclampsia and chronic hypertension in Norwegian families. Pregnancy Hypertension. 138-139.
  • 2013. DETERMINANTS OF VITAMIN D STATUS IN PATIENTS WITH STABLE ANGINA. Annals of Nutrition and Metabolism. 241-241.
  • 2013. Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi. Gynekologen. 43-44.
  • 2012. Relationship between plasma choline and betaine levels and risk of acute myocardial infarction in patients with stable coronary heart disease. European Heart Journal. 132-132.
  • 2012. INVESTIGATING GENETIC PREDISPOSITION AND CLINICAL OCCURRENCE OF PREECLAMPSIA AND CARDIOVASCULAR DISEASE THROUGH A FAMILY-BASED DESIGN. Placenta. A82-A82.
  • 2009. Dietary intake of very long chain n-3 fatty acids and cardiovascular events in Norwegian patients with coronary artery disease: a cohort study. European Journal of Cardiovascular Prevention & Rehabilitation. P340-P340.
  • 2009. Detection of non-viable myocardium by 3T MRI in patients without obstructive coronary artery disease. Cardiology. 88-89.
  • 2009. Delayed contrast-enhancement and left ventricular remodelling demonstrated at high-field 3T MRI of patients with suspected coronary artery disease. Cardiology. 82-83.
  • 2008. The ratio of apolipoproteins ApoB/ApoA1 as a predictor of angiographic progression of atherosclerosis in patients with coronary artery disease. Circulation. E345-E346.
  • 2008. The effect of homocysteine-lowering B-vitamin intervention on angiographic coronary artery disease may be adverse - A WENBIT sub-study. Circulation. E334-E334.
  • 2008. Homocysteine lowering B-vitamin therapy improves coronary flow in patients with stable coronary artery disease, a WENBIT substudy. Circulation. E487-E487.
  • 2008. Homocysteine lowering B-vitamin therapy and in-stent restenosis. A WENBIT sub study. Circulation. E472-E473.
  • 2008. Homocysteine and markers of immune activation as predictors of mortality in stable angina patients. Circulation. E351-E351.
  • 2008. B6 vitamers and long term mortality in patients with stable angina. Circulation. E347-E347.
  • 2008. Asymmetric and symmetric dimethylarginine are weaker predictors than homocysteine of long-term mortality in both men and women with stable angina. Circulation. E342-E342.
  • 2007. Predictors of plasma choline and betaine: The Hordaland Homocysteine Study. Clinical Chemistry and Laboratory Medicine. A18-A19.
  • 2005. The Effect of Homocysteine Lowering Therapy on Inflammatory Markers Neopterin and CRP in Patients with Stable Coronary Artery Disease. A substudy of the Western Norway B-vitamin Intervention Trial (WENBIT). Haematalogica Reports. 66-66.
  • 2005. Effect of homocysteine lowering therapy on coronary endothelial function in patients with stable coronary artery disease. A substudy of the Western Norway B-vitamin Intervention Trial (WENBIT). European Heart Journal. 477-477.
  • 2005. Effect of Homocysteine Lowering Therapy on Coronary Endothelial Function in Patients with Stable Coronary Artery Disease. Haematalogica Reports. 10-10.
Vitenskapelig oversiktsartikkel/review
  • 2015. The chromosome 9p21 CVD- and T2D-associated regions in a Norwegian population (the HUNT2 survey). 9 sider.
  • 2012. The Role of Long-Chained Marine N-3 Polyunsaturated Fatty Acids in Cardiovascular Disease. 15 sider.
  • 2010. Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific Mortality Meta-analysis of 8 Randomized Trials Involving 37 485 Individuals. 1622-1631.
  • 2010. Circulating folate, vitamin B-12, homocysteine, vitamin B-12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. 1632-1642.

Se fullstendig oversikt over publikasjoner i CRIStin.